Cerebrospinal fluid YKL-40 relates to white matter hyperintensity progression in females but not males over a 6-year period.

脑脊液 YKL-40 与女性(而非男性)6 年内的白质高信号进展有关

阅读:6
作者:Peterson Amalia J, Sun Yunyi, Archer Derek B, Adegboye Hailey A, Moore Elizabeth E, Deberghes Isabella, Pechman Kimberly R, Shashikumar Niranjana, Robb W Hudson, Workmeister Abigail W, Jackson T Bryan, Liu Dandan, Dumitrescu Logan, Davis L Taylor, Landman Bennett A, Blennow Kaj, Zetterberg Henrik, Hohman Timothy J, Jefferson Angela L
INTRODUCTION: Neuroinflammation may have sex-specific effects on white matter injury and impact the development of dementia. METHODS: Human chitinase-3-like protein-1 (YKL-40) concentrations at baseline were related to white matter hyperintensity (WMH) volume, free water (FW), and FW-corrected fractional anisotropy using linear effects models (for cross-sectional outcomes) and linear mixed-effects models (for longitudinal outcomes), adjusting for demographic and medical risk factors. Models were repeated with a sex-interaction term and then stratified by sex. RESULTS: In stratified analyses, greater baseline YKL-40 concentrations were associated with increased WMHs in females but not males in the parietal (females p = 0.04; males p = .34) and temporal lobes (females p = 0.005; males = p = 0.71) longitudinally. YKL-40 associations with FW and FW-corrected fractional anisotropy were null. DISCUSSION: Results suggest that neuroinflammation is a sex-specific driver of WMHs (but not FW) in females. Differential sequelae of neuroinflammation may be one reason that females have a greater burden of WMHs. HIGHLIGHTS: ·Cerebrospinal fluid YKL-40 is associated with white matter hyperintensities in females but not males cross-sectionally and longitudinally.·Longitudinally, cerebrospinal fluid YKL-40 is associated with white matter hyperintensities in the parietal and temporal lobes, regions that exhibit early pathological changes in Alzheimer's disease .·Cerebrospinal fluid YKL-40 is not associated with white matter microstructural measures.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。